查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611989

急性肾损伤治疗市场：按产品类型、疾病类型、最终用户划分 - 全球预测 2025-2030

Acute Kidney Injury Treatment Market (AKI) by Product (Dialysis, Drug Therapy), Injury Type (Intrinsic-Renal Acute Kidney Injury, Post-Renal Acute Kidney Injury, Pre-Renal Acute Kidney Injury), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年急性肾损伤治疗市场规模为18.7亿美元，预计2024年将达20.2亿美元，复合年增长率为7.81%，2030年预计将达31.7亿美元。

急性肾损伤（AKI）治疗是医疗保健市场中不断发展的一部分，其根源在于需要有效的治疗性介入来应对肾功能的突然下降。 AKI 的发病率和死亡率较高，因此需要治疗，早期准确的干预至关重要。目前的应用重点是促进肾臟恢復、液体平衡、管理电解质异常以及最大限度地减少进一步的肾臟损伤。这些治疗在医院、透析中心、加护病房等进行，反映了整个重症加护环境的高端使用范围。影响该市场的主要成长要素包括糖尿病和高血压等慢性病的流行、人口老化以及诊断和监测技术的进步。潜在的治疗机会在于开发能够显着改善患者预后的创新治疗方法，包括干细胞疗法、下一代透析产品和用于早期检测 AKI 的生物标记。透过利用与学术机构的研究合作，公司可以快速创新并扩大其治疗组合。然而，这个市场面临着治疗成本高、缺乏熟练的肾臟病专家以及重症患者多重器官衰竭的复杂性等限制。此外，监管挑战和广泛临床检验的需求可能会延迟产品上市。儘管存在这些挑战，人工智慧驱动的预测分析、个人化医疗方法和新型肾臟支援设备等创新领域可能为市场的显着成长铺平道路。 AKI 治疗市场的特点是充满活力，强调技术发展和治疗进步。对市场动态的洞察指南公司做出明智的投资决策、优先考虑研发工作并进行策略合作。全面的市场分析表明，解决未满足的医疗需求和提高现有治疗的有效性是 AKI 治疗业务可持续扩张的关键途径。

主要市场统计
基准年[2023] 18.7亿美元
预测年份 [2024] 20.2亿美元
预测年份 [2030] 31.7亿美元
复合年增长率（%） 7.81%

市场动态：快速发展的急性肾损伤治疗市场的关键市场洞察

供应和需求的动态交互作用正在改变急性肾损伤治疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 肾衰竭和肾臟相关疾病的增加
    • 核准用于治疗肾臟疾病的药物数量增加
    • 政府努力提高肾臟健康意识
  • 市场限制因素
    • 治疗费用上涨且无法报销
  • 市场机会
    • 治疗方法进展扩大了肾臟治疗选择并改善了疾病检测
    • 新医院提供肾臟护理并改善门诊护理
  • 市场挑战
    • 关于某些肾损伤治疗方案的严格规定

波特五力：开拓急性肾损伤治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解急性肾损伤治疗市场的外部影响

外部宏观环境因素在塑造急性肾损伤治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解急性肾损伤治疗市场的竞争状况

对急性肾损伤治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵急性肾损伤治疗市场供应商的绩效评估

FPNV定位矩阵是评估急性肾损伤治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划急性肾损伤治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对急性肾损伤治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肾衰竭和肾臟相关疾病的增加
      • 肾臟疾病治疗的核准数量增加
      • 政府采取措施提高人们对肾臟健康的认识
    • 抑制因素
      • 治疗费用上涨且无法报销
    • 机会
      • 增加肾臟治疗选择和改善疾病检测的进展
      • 新医院提供肾臟护理并改善门诊护理
    • 任务
      • 关于某些肾损伤治疗方案的严格规定
  • 市场区隔分析
    • 产品：增加研究活动以改善透析治疗
    • 疾病类型：对肾损伤根本原因的认识将导致内源性急性肾损伤治疗方法的开发
    • 最终用户：门诊护理的改进将增加门诊手术中心 (ASC) 的普及率
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章急性肾损伤治疗市场：副产品

  • 透析
    • 连续性肾臟替代治疗（CRRT）
    • 间歇性血液透析机
    • 持续低效透析（SLED）
  • 药物治疗
    • 抗生素
    • 利尿剂
    • 免疫抑制剂

第七章依损伤类型分類的急性肾损伤治疗市场

  • 内源性肾性急性肾损伤
  • 肾后性急性肾损伤
  • 肾前性急性肾损伤

第八章急性肾损伤治疗市场：依最终使用者分类

  • 门诊手术中心
  • 医院

第九章北美及南美急性肾损伤治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区急性肾损伤治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲急性肾损伤治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 诺华斥资高达 35 亿美元收购 Chinook，扩大肾臟病产品线
    • CalciMedica 宣布与 Graybug Vision 合併并同时完成私募配售
    • SeaStar Medical 获得 FDA核准开始研究选择性细胞去除装置，以减少患有急性肾损伤的成年人的发炎
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Alloksys Life Sciences BV
  • Amgen Inc.
  • Angion Biomedica Corp.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Bayer AG
  • bioMerieux SA
  • Dr. Reddys Laboratories Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Reata Pharmaceuticals Inc. by Biogen Inc.
  • Rockwell Medical, Inc.
  • Silver Creek Pharmaceuticals, Inc.
  • Stealth BioTherapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-035DA3C63706

The Acute Kidney Injury Treatment Market was valued at USD 1.87 billion in 2023, expected to reach USD 2.02 billion in 2024, and is projected to grow at a CAGR of 7.81%, to USD 3.17 billion by 2030.

Acute Kidney Injury (AKI) treatment is an evolving segment in the healthcare market, rooted in the need for effective therapeutic interventions to manage sudden kidney function loss. The necessity of AKI treatment stems from its high morbidity and mortality rates, making early and accurate interventions crucial. Current applications focus on enhancing renal recovery, managing fluid balance, electrolyte disturbances, and minimizing further renal damage. These treatments serve hospitals, dialysis centers, and intensive care units, reflecting a high end-use scope across critical care settings. Key growth factors influencing this market include the rising prevalence of chronic diseases like diabetes and hypertension, an aging population, and advancements in diagnostic techniques and monitoring technologies. Potential opportunities lie in the development of innovative therapies such as stem-cell treatment, next-gen dialysis products, and biomarkers for early AKI detection, which can significantly enhance patient outcomes. Companies can leverage collaborative research with academic institutions to fast-track innovation and widen therapeutic portfolios. However, the market faces limitations including high treatment costs, the shortage of skilled nephrologists, and the complex nature of multi-organ failure in critical patients. Moreover, regulatory challenges and the need for extensive clinical validation can delay product launches. Despite these challenges, innovation areas such as AI-driven predictive analytics, personalized medicine approaches, and novel kidney support devices can pave the way for substantial market growth. The AKI treatment market is characterized by a dynamic nature, with a strong emphasis on technological developments and therapeutic advancements. Insights into market dynamics can guide businesses to make informed investment decisions, prioritize R&D efforts, and collaborate strategically. Comprehensive market analysis reveals that addressing unmet medical needs and improving existing treatment efficacy are pivotal pathways toward sustainable business expansion in the AKI treatment landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.87 billion
Estimated Year [2024] USD 2.02 billion
Forecast Year [2030] USD 3.17 billion
CAGR (%) 7.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acute Kidney Injury Treatment Market

The Acute Kidney Injury Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of kidney failures and kidney-related diseases
    • Growing number of drug approvals for the treatment of kidney disorders
    • Government initiatives to raise awareness about kidney health
  • Market Restraints
    • High cost of availing treatment and lack of reimbursements
  • Market Opportunities
    • Advancements to enhance kidney treatment options and improve disease detection
    • New hospitals providing kidney treatment and improvements in outpatient care
  • Market Challenges
    • Stringent regulations concerning certain kidney injury treatment options

Porter's Five Forces: A Strategic Tool for Navigating the Acute Kidney Injury Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acute Kidney Injury Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acute Kidney Injury Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acute Kidney Injury Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acute Kidney Injury Treatment Market

A detailed market share analysis in the Acute Kidney Injury Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acute Kidney Injury Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acute Kidney Injury Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acute Kidney Injury Treatment Market

A strategic analysis of the Acute Kidney Injury Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acute Kidney Injury Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alloksys Life Sciences B.V., Amgen Inc., Angion Biomedica Corp., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Bayer AG, bioMerieux SA, Dr. Reddys Laboratories Ltd., Fresenius Medical Care AG & Co. KGaA, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Reata Pharmaceuticals Inc. by Biogen Inc., Rockwell Medical, Inc., Silver Creek Pharmaceuticals, Inc., Stealth BioTherapeutics, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Acute Kidney Injury Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Dialysis and Drug Therapy. The Dialysis is further studied across Continuous Renal Replacement Therapy (CRRT), Intermittent Hemodialysis, and Sustained Low-Efficiency Dialysis (SLED). The Drug Therapy is further studied across Antibiotics, Diuretics, and Immunosuppressive Agents.
  • Based on Injury Type, market is studied across Intrinsic-Renal Acute Kidney Injury, Post-Renal Acute Kidney Injury, and Pre-Renal Acute Kidney Injury.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of kidney failures and kidney-related diseases
      • 5.1.1.2. Growing number of drug approvals for the treatment of kidney disorders
      • 5.1.1.3. Government initiatives to raise awareness about kidney health
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of availing treatment and lack of reimbursements
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements to enhance kidney treatment options and improve disease detection
      • 5.1.3.2. New hospitals providing kidney treatment and improvements in outpatient care
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations concerning certain kidney injury treatment options
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising number of research initiatives to improve dialysis treatment
    • 5.2.2. Injury type: Awareness about underlying causes of kidney injury leading to the creation of treatments for Intrinsic-Renal Acute Kidney Injury
    • 5.2.3. End-user: Improvements in outpatient care leading to rising prevalence of ambulatory surgical centers (ASCs)
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acute Kidney Injury Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Dialysis
    • 6.2.1. Continuous Renal Replacement Therapy (CRRT)
    • 6.2.2. Intermittent Hemodialysis
    • 6.2.3. Sustained Low-Efficiency Dialysis (SLED)
  • 6.3. Drug Therapy
    • 6.3.1. Antibiotics
    • 6.3.2. Diuretics
    • 6.3.3. Immunosuppressive Agents

7. Acute Kidney Injury Treatment Market, by Injury Type

  • 7.1. Introduction
  • 7.2. Intrinsic-Renal Acute Kidney Injury
  • 7.3. Post-Renal Acute Kidney Injury
  • 7.4. Pre-Renal Acute Kidney Injury

8. Acute Kidney Injury Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Acute Kidney Injury Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Acute Kidney Injury Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Acute Kidney Injury Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novartis to Buy Chinook for Up to USD 3.5 Billion, Expanding Kidney Disease Pipeline
    • 12.3.2. CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
    • 12.3.3. SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alloksys Life Sciences B.V.
  • 3. Amgen Inc.
  • 4. Angion Biomedica Corp.
  • 5. Asahi Kasei Medical Co., Ltd.
  • 6. B. Braun Melsungen AG
  • 7. Baxter International, Inc.
  • 8. Bayer AG
  • 9. bioMerieux SA
  • 10. Dr. Reddys Laboratories Ltd.
  • 11. Fresenius Medical Care AG & Co. KGaA
  • 12. GlaxoSmithKline PLC
  • 13. Johnson & Johnson Services, Inc.
  • 14. Merck & Co., Inc.
  • 15. Novartis AG
  • 16. Otsuka Pharmaceutical Co., Ltd.
  • 17. Pfizer Inc.
  • 18. Reata Pharmaceuticals Inc. by Biogen Inc.
  • 19. Rockwell Medical, Inc.
  • 20. Silver Creek Pharmaceuticals, Inc.
  • 21. Stealth BioTherapeutics, Inc.
  • 22. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ACUTE KIDNEY INJURY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ACUTE KIDNEY INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ACUTE KIDNEY INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACUTE KIDNEY INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACUTE KIDNEY INJURY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY SUSTAINED LOW-EFFICIENCY DIALYSIS (SLED), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INTRINSIC-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY POST-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRE-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. ACUTE KIDNEY INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. ACUTE KIDNEY INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023